StockNews.com lowered shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a strong-buy rating to a buy rating in a research note released on Tuesday. Other analysts have also recently issued research reports about the stock. TD Cowen increased their price target on shares of Regeneron Pharmaceuticals from $1,020.00 to $1,030.00 and gave the stock […]
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
AJOVista LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 163 shares of the biopharmaceutical company’s stock, valued at approximately $143,000. Other institutional investors also recently made changes to their positions in the company. […]
Weekly Upgrades and Downgrades | InvestorPlace investorplace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorplace.com Daily Mail and Mail on Sunday newspapers.